Filter
7104
Filtered Results: 7104
Text search:
health
care
products
Featured
Recommendations
737
New Publications
1883
Language
Document type
No document type
3654
Studies & Reports
1231
Guidelines
1036
Manuals
449
Strategic & Response Plan
303
Fact sheets
177
Training Material
133
Situation Updates
62
Infographics
23
Resource Platforms
17
Brochures
14
Online Courses
4
App
1
Countries / Regions
Global
336
India
280
Kenya
195
Sierra Leone
143
Ethiopia
136
South Africa
135
Nigeria
134
Western and Central Europe
126
Liberia
125
Nepal
115
Latin America and the Carribbean
110
Uganda
106
Malawi
95
Myanmar / Burma
94
Ghana
92
Rwanda
90
Africa
89
Tanzania
87
Zambia
84
Ukraine
83
Bangladesh
80
Syria
74
Namibia
68
Philippines
64
South–East Asia Region
53
Congo, Democratic Republic of
49
Zimbabwe
43
Haiti
43
Eastern Europe
43
Guinea
40
Asia
39
West and Central Africa
38
Mozambique
36
Indonesia
36
Lesotho
35
Cambodia
35
East and Southern Africa
35
South Sudan
33
Senegal
31
Eastern Europe and Central Asia
31
Russia
31
Middle East and North Africa
26
Burkina Faso
24
Yemen
24
Eswatini/ Swaziland
24
Pakistan
23
Venezuela
21
Cameroon
19
Germany
19
Brazil
19
Botswana
19
Sudan
17
Afghanistan
15
USA
15
Jordan
14
Western Pacific Region
14
Benin
13
Vietnam
13
Moldova
13
Central African Republic
13
China
12
Mali
12
Colombia
11
Lebanon
11
Madagascar
11
Thailand
10
North America
10
Côte d’Ivoire / Ivory Coast
10
Somalia
10
Tajikistan
9
Turkey
9
Albania
9
Iran
8
Georgia
8
North Macedonia
7
Peru
7
Iraq
7
Laos
6
Kyrgyzstan
6
Paraguay
6
United Kingdom
6
Argentina
6
Sri Lanka
6
Ecuador
6
Timor Leste/ East Timor
5
Serbia
5
Kazakhstan
5
Papua New Guinea
5
Egypt
5
Poland
5
Chad
5
Bhutan
5
Chile
4
Saudi Arabia
4
Japan
4
Spain
4
Southern Africa
4
Romania
4
Palestine
4
Fiji
3
Uzbekistan
3
Guinea-Bissau
3
Croatia
3
Hungary
3
Ireland
3
Turkmenistan
3
Mauritius
3
Tunisia
3
Portugal
3
Libya
3
Guatemala
3
North Korea
2
El Salvador
2
Gambia
2
Togo
2
Canada
2
Singapore
2
Estonia
2
Niger
2
Burundi
2
Mongolia
2
Qatar
2
Bulgaria
2
Armenia
2
Jamaica
2
Azerbaijan
2
Bosnia and Herzegovina
2
Bolivia
2
Slovakia
2
Honduras
2
Angola
2
Switzerland
1
Mexico
1
Australia
1
Congo-Brazzaville
1
Malaysia
1
Vanuatu
1
Morocco
1
Mauritania
1
Dominican Republic
1
Gabon
1
Denmark
1
France
1
Maldives
1
Algeria
1
Morocco
1
Belarus
1
Israel
1
Latvia
1
Belize
1
Costa Rica
1
Guyana
1
Panama
1
Nicaragua
1
Djibouti
1
Greece
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
2484
Clinical Guidelines
623
Key Resources
453
Women & Child Health
424
Public Health
420
Capacity Building
134
Pharmacy & Technologies
103
Annual Report MEDBOX
1
Toolboxes
COVID-19
647
HIV
466
Mental Health
423
TB
345
Planetary Health
254
AMR
249
Rapid Response
232
Disability
230
NTDs
220
Ebola & Marburg
212
Caregiver
211
Pharmacy
200
Conflict
188
NCDs
129
Global Health Education
124
Health Financing Toolbox
110
Refugee
105
Malaria
105
Natural Hazards
91
Zika
58
Specific Hazards
54
Cholera
51
Polio
30
Social Ethics
26
Typhoon
4
Promoting health and preventing disease is a critical component of the effort required to achieve Universal Health Coverage (UHC). to date, efforts to achieve UHC have focused mostly on strengthening health systems and their capacities to provide curative care. However, experience from the COVID-19 ...
This technical guidance outlines current evidence, knowledge and best practice relating to incidences of violence and injuries among refugees and migrants in the WHO European Region. It highlights key principles, summarizes priority actions and challenges, maps existing international commitments and...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
Guidelines for the Prevention and Containment of Antimicrobial Resistance in South African Hospitals
These guidelines form part of efforts to institutionalise the prevention and containment of antimicrobial resistance (AMR) in health care facilities in South Africa, as outlined in the Antimicrobial Resistance Strategic Framework and Implementation Plan. The focus of these guidelines is on two inte...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Turkey. This report provides evidence through three analyses that NCDs reduce economic output, and di...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
Cancer centres are a major resource in ensuring a comprehensive approach to cancer treatment and its planning. As part of a new roadmap developed by WHO and IAEA to help countries design national cancer control programmes, this publication proposes a framework to develop a cancer centre and/or to st...
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
This leaflet provides support and advice for adults who are recovering from COVID-19. It can be used by individuals after hospitalization from the illness and those in the community who did not need hospitalization. The leaflet can complement care received from health care professionals. This is the...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three ...
WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents
recommended
The practical guidance in the operational handbook aims to inform the development or revision of national policies and related implementation guidance on the management of TB in children and adolescents under programmatic circumstances and at different levels of the health system. The operational ha...
Communities can play a critical role in suicide prevention. Facilitating community engagement in suicide prevention is an important task. The toolkit is a step-by-step guide for communities to engage in suicide prevention activities and have ownership of the process and keep efforts sustained. It is...
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products; storage of pharmaceutical products; and distribut...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
The World Health Organization invites clinicians and patients to collect information on COVID-19 in a systematic way and contribute clinical data to the WHO Clinical Platform to expand our knowledge on Post-COVID-19 condition, and support patient care and public health interventions.
WHO’s Post...
